Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Just Buy This 15% Yielder: The Procter & Gamble Company (PG)

The Procter & Gamble Company (NYSE: PG) is an American consumer goods company with products that include pet foods, cleaning agents and personal care products.

Procter & Gamble’s Earnings

P&G beat the analysts’ estimates in 2Q 2013 and reported earnings per share of $1.39; guidance range was $1.18 to $1.25 per share. Core earnings per share grew 12% to $1.22, while core operating income was up 0.11%. Core gross margin also increased by 0.11%, thanks to cost savings and higher productivity. The free cash flow stood at $3.1 billion in the quarter, which also beat the company’s estimates. Out of this, $1.6 billion was used up in dividends while $1.4 billion was spent in share repurchases.

In the U.S. laundry detergents division, the Gain and Tide brands have done really well. Tide’s market share was up 1.5% from the prior year, while Gain’s share was close to 15%. The auto dishwashing detergents have also shown a significant growth during the past year, as Cascade’s market share has risen 1.5% to 60%. Gillette’s market share also grew 2% to 74% in the U.S. blades and razors segment. The Fusion franchise has gone up more than 1% to 37.5%, while the MACH3 enjoys a healthy 21% market share.

In the developing markets, organic sales were up 7% during the latest quarter. The BRIC markets grew by 11%, with India and Brazil yielding a growth of 20%. One of the key developments in this region was the expansion of the company’s oral care portfolio. Over the last 4 years, P&G has expanded its oral care portfolio to 34 countries. Oral care shipments grew more than 50% in 2Q13 amid the launch of 3D white toothpastes. Moreover, the company has plans of launching its oral care in Australia this year. Gillette’s latest breakthrough, Gillette Guard, has shown a lot of promise in India and Egypt lately; the company has further plans of testing it in other developing markets where the double-edge blades are still the way to go.


Procter & Gamble is trading at a forward P/E (1yr) of 17.29x and has a mean recommendation of 2.2 on the sell side. Using the industry’s earnings multiple of 15.6x, we can value P&G’s stock. However, as P&G is expected to perform well above its industry, we would value it using a premium of 20%. Hence, a forward P/E (1yr) of 18.72x would be used.

According to high estimates, we value P&G at $85.18, depicting an upside potential of almost 12%. Incorporating a dividend yield of 3% into this yields a total return of 15%. In short, P&G is one of the top buys in its industry, if not the best.


P&G’s biggest rival, Unilever plc (ADR) (NYSE: UL), recently released its 2012 earnings. The company’s revenues were up 10.5% to €51.3 billion. Earnings per share grew 5% to €5.14, while the core earnings per share were up to €1.57, thanks to high levels of operational efficiency. While the Americas grew by 7.9%, Europe saw a growth of almost 0.8%. Home care segment grew by 10.3% whereas the Personal Care segment saw a growth of 10%. Unilever is trading at a forward P/E (1yr) of 17.28x, has a PEG of 3.46, and a mean recommendation of 2.3 on the sell side. This suggests that though the company is doing great, its stock is still rather expensive when compared to P&G. In short, it’s a good buy but not as attractive as P&G.